Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
I took my time and went through what felt like a million clinics to narrow it down to these 10
New opportunities lie in: Expansion into emerging markets with tailored GLP-1 therapies Development of combination therapies to enhance efficacy Investment in digital health platforms for patient engagement By 2035, the GLP-1 Drug Market is expected to achieve substantial growth and innovation
doi:10.1099/mic.0.077826-0
Glucose/galactose adapted cells were cultured in DMEM containing 10% dFBS, 100 U ml 1 penicillin and 100 g ml 1 streptomycin, 1 mM sodium pyruvate and 25 mM glucose (Sigma-Aldrich, G7021-1KG) or 25 mM galactose (Sigma-Aldrich, G5388-500G) for a minimum of 1 month before being used experimentally
